• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Eschenbach's low vision lens

Article

Unilens Vision Inc. and Eschenbach Optik announced that Eschenbach Optik is the exclusive worldwide distributor of the UniVision low vision lens.

Largo, FL, and Ridgefield, CT-Unilens Vision Inc. and Eschenbach Optik announced that Eschenbach Optik is the exclusive worldwide distributor of the UniVision low vision lens. Eschenbach Optik of America Inc. will serve as the exclusive distributor for North and South America. Eschenbach Optik GmbH + Co. will be the exclusive distributor in the rest of the world.

"Our recent agreement is an exciting change for both companies and for low vision practitioners," said Ken Bradley, president of Eschenbach Optik of America. "Eschenbach Optik brings its expertise in marketing and distribution of high-quality low vision products to the relationship and Unilens brings its expertise in the design and manufacture of high-quality optics. Together, the two companies will have more impact on the market and more value to deliver to low vision practitioners and consumers."

Michael Pecora, president and chief executive officer of Unilens, said, "The partnership will allow our UniVision product to be aggressively marketed throughout the world, offering eye-care professionals a truly unique specialty product to serve the expanding low vision market."

Additionally, a new UniVision diagnostic system-created through the collaboration between Eschenbach and Unilens-was introduced this fall.

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.